Family Heart Foundation partners with health systems on heart disease screeningThis program utilizes a machine-learning model to identify people who are likely to have elevated Lp(a). Surescripts partners with TPG TPG, a global alternative asset management firm, will join the Surescripts ownership group as a majority investor. Teva intros generic Sandostatin LAR Depot Octreotide acetate for injectable suspension is indicated to treat acromegaly and severe diarrhea for carcinoid syndrome. Walmart expands Cancer Centers of Excellence program for associates A collaboration with the Mayo Clinic, the center provides associates access to top cancer specialists. Fresenius Kabi, Formycon receive FDA nod for Stelara biosimilar Otulfi is approved for the treatment of Crohn’s disease, ulcerative colitis, moderate to severe plaque psoriasis and active psoriatic arthritis. Thrifty White Health honored at UCare’s ‘A Salute to Excellence!’ awards ceremony Thrifty White Health received the Innovation Award. Hikma celebrates 40 years of Hatch-Waxman drug savings The Drug Price Competition and Patent Term Restoration Act of 1984 established the modern system for regulating generic drugs in the United States. Aetna details 2025 Medicare plan offering for members Aetna is offering a wide array of Medicare Advantage plan options, including $0 monthly plan premium and $0 primary care copay, among others. Alembic receives FDA nod for 2 generics The FDA has approved Alembic's generic Albenza and generic Invega. Surescripts partners with CLEAR to enhance identity verification technology infrastructure Clear’s identity proofing technology will support Surescripts Network Alliance participants, including providers, pharmacies and payers. First Previous 11 12 13 14 15 Next Last
